Molecular mechanism of sulphonylurea block of K(ATP) channels carrying mutations that impair ATP inhibition and cause neonatal diabetes.
Sulphonylurea drugs are the therapy of choice for treating neonatal diabetes (ND) caused by mutations in the ATP-sensitive K(+) channel (KATP channel). We investigated the interactions between MgATP, MgADP, and the sulphonylurea gliclazide with KATP channels expressed in Xenopus oocytes. In the abse...
Principais autores: | Proks, P, De Wet, H, Ashcroft, F |
---|---|
Formato: | Journal article |
Idioma: | English |
Publicado em: |
2013
|
Registros relacionados
-
Phentolamine block of ATP-sensitive K+ channels does not involve interaction with the sulphonylurea receptor, SUR1.
por: Proks, P, et al.
Publicado em: (1997) -
Interaction of MgATP with the sulphonylurea subunit activates ATP sensitive K-channels receptor
por: Gribble, F, et al.
Publicado em: (1998) -
How ATP inhibits the open K(ATP) channel.
por: Craig, T, et al.
Publicado em: (2008) -
Analysis of the differential modulation of sulphonylurea block of beta-cell and cardiac ATP-sensitive K+ (K(ATP)) channels by Mg-nucleotides.
por: Reimann, F, et al.
Publicado em: (2003) -
Mechanism of K-ATP channel inhibition by ATP
por: Ashcroft, F, et al.
Publicado em: (1998)